基于PI3K-AKT-Nrf2/BDNF通路研究逍遥散抗抑郁作用的机制

被引:30
作者
罗杰
方洋
曾九僧
纪雅菲
刘蓉
曾南
机构
[1] 成都中医药大学药学院
关键词
逍遥散; 嗅球摘除; 氧化应激; BDNF; Nrf2-Keap1; PI3K-AKT;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
100806 [中药药理学];
摘要
目的:建立嗅球摘除(Olfactory Bulbectomy,OB)抑郁大鼠模型,从PI3K-AKT-Nrf2/BDNF角度探讨逍遥散抗抑郁作用机制。方法:手术摘除嗅球方法建立OB大鼠抑郁模型,将模型大鼠分为模型对照组、逍遥散15、30 g原生药/kg和盐酸氟西汀0.01 g/kg组,并设假手术组,各组大鼠连续灌胃相应药物或蒸馏水30天。进行大鼠旷场试验和糖水偏好率测定,腹主动脉取血分离血清,取大鼠皮质、海马部位备用。采用分光光度计法检测血清GSH、SOD及皮质MDA活力或含量,实时荧光定量聚合酶链式反应(Real-time PCR)检测OB大鼠皮质和海马部位Nrf2、Keap1、GPX3、HO-1、NQO1、OGG1 mRNA的表达水平,采用蛋白免疫印迹法(Western blot)检测Nrf2、HO-1、SOD1、PI3K、AKT、p-AKT、TrkB、BDNF蛋白表达水平。结果:与假手术组比较,模型对照组大鼠血清GSH、SOD水平显著降低,且皮质MDA含量明显升高;皮质、海马部位Nrf2、Keap1、GPX3、HO-1 mRNA表达水平及SOD-1、HO-1、TrkB、BDNF蛋白表达水平显著下调,皮质部位PI3K蛋白表达和p-AKT/AKT比值显著降低。与模型对照组比较,15、30 g/kg逍遥散给药30 d能提高大鼠糖水偏好率,对抗自主活动异常,显著提高血清GSH、SOD水平,并降低皮质MDA含量;能显著上调皮质、海马部位Nrf2、HO-1、皮质Keap1、NQO1及海马GPX3 mRNA的表达水平,显著上调皮质、海马部位SOD1、HO-1、TrkB、BDNF蛋白表达水平及p-AKT/AKT比值,对皮质、海马部位OGG1mRNA及皮质Nrf2、海马PI3K的蛋白表达水平有上调趋势。结论:逍遥散对OB模型大鼠的行为学异常及氧化应激表现有对抗作用,其激活OB大鼠PI3K-AKT-Nrf2信号通路从而改善氧化应激状态、上调BDNF水平可能是其抗抑郁作用机制之一。
引用
收藏
页码:2 / 6
页数:5
相关论文
共 16 条
[1]
方剂学.[M].段富津; 主编.上海科学技术出版社.1995,
[2]
Apocynum venetum leaf extract reverses depressive-like behaviors in chronically stressed rats by inhibiting oxidative stress and apoptosis.[J].Xiangting Li;Ting Wu;Zhonghai Yu;Tingting Li;Jingsi Zhang;Zhennian Zhang;Min Cai;Wen Zhang;Jun Xiang;Dingfang Cai.Biomedicine & Pharmacotherapy.2018,
[3]
Fluoxetine reverses behavior changes in socially isolated rats: role of the hippocampal GSH-dependent defense system and proinflammatory cytokines [J].
Peric, Ivana ;
Stanisavljevic, Andrijana ;
Gass, Peter ;
Filipovic, Dragana .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2017, 267 (08) :737-749
[4]
Olfactory bulbectomy in mice triggers transient and long-lasting behavioral impairments and biochemical hippocampal disturbances.[J].Roberto Farina de Almeida;Marcelo Ganzella;Daniele Guilhermano Machado;Samanta Oliveira Loureiro;Douglas Leffa;André Quincozes-Santos;Letícia Ferreira Pettenuzzo;Marta Maria Medeiros Frescura Duarte;Thiago Duarte;Diogo Onofre Souza.Progress in Neuropsychopharmacology & Biological Psychiatry.2017,
[5]
Oxidative stress; inflammation and treatment response in major depression.[J].Daniel Lindqvist;Firdaus S. Dhabhar;S. Jill James;Christina M. Hough;Felipe A. Jain;F. Saverio Bersani;Victor I. Reus;Josine E. Verhoeven;Elissa S. Epel;Laura Mahan;Rebecca Rosser;Owen M. Wolkowitz;Synthia H. Mellon.Psychoneuroendocrinology.2017,
[6]
Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats.[J].David Martín-Hernández;Álvaro G. Bris;Karina S. MacDowell;Borja García-Bueno;José L.M. Madrigal;Juan C. Leza;Javier R. Caso.Neuropharmacology.2016,
[7]
Baicalin Reverses Depressive-Like Behaviours and Regulates Apoptotic Signalling Induced by Olfactory Bulbectomy [J].
Yu, Hai-Yang ;
Yin, Zhu-Jun ;
Yang, Shui-Jin ;
Ma, Shi-Ping ;
Qu, Rong .
PHYTOTHERAPY RESEARCH, 2016, 30 (03) :469-475
[8]
Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression.[J].Indira Mendez-David;Laurent Tritschler;Zeina El Ali;Marie-Hélène Damiens;Marc Pallardy;Denis J. David;Saadia Kerdine-Römer;Alain M. Gardier.Neuroscience Letters.2015,
[9]
Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats.[J].Sawsan Aboul-Fotouh.Pharmacology; Biochemistry and Behavior.2013,
[10]
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets.[J].Filippo Caraci;Agata Copani;Ferdinando Nicoletti;Filippo Drago.European Journal of Pharmacology.2009, 1